Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MegaRed is a leading consumer health brand specializing in high-quality krill oil supplements, currently owned by the global consumer goods company Reckitt. Originally developed by Schiff Nutrition International, the brand became a cornerstone of Reckitt's health portfolio following a $1.4 billion acquisition in 2012. MegaRed's product line is centered on the use of Antarctic krill oil, which provides omega-3 fatty acids (EPA and DHA) in a phospholipid form that is marketed as being more easily absorbed by the human body than traditional fish oil. The brand offers a variety of formulations targeting cardiovascular health, joint comfort, and cognitive support. MegaRed maintains a strong retail presence globally and is recognized for its "no fishy aftertaste" value proposition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MegaRed.